Reactivation of herpes simplex virus 2 presenting as recurrent acute retinal necrosis following COVID-19 vaccination.

Reactivation of herpes simplex virus 2 presenting as recurrent acute retinal necrosis following COVID-19 vaccination.

Publication date: Jul 16, 2024

Acute retinal necrosis (ARN) is a vision-threatening uveitis caused by herpesviruses reactivation, which has recently been suggested to be associated with COVID-19 infection and after vaccination against it. We present the case of a 58-year-old Japanese woman with ARN in the left eye due to herpes simplex virus 2 (HSV2) two days after receiving the fifth dose of the BNT162b2 mRNA COVID-19 vaccine. The patient demonstrated an ARN history in the right eye and had been treated for it. The patient was administered oral steroids and immunosuppressive drugs for mixed connective tissue disease and organizing pneumonia. The patient was treated with intravenous acyclovir and foscarnet, and a vitrectomy was performed for retinal detachment. The lesion took approximately two months to scar. This report suggests that patients with an ARN history might be at risk of ARN recurrence because of the reactivation of the herpes simplex virus induced by COVID-19 vaccination.

Concepts Keywords
Herpesviruses acute retinal necrosis
Japanese COVID-19 vaccine
Old herpes simplex virus
Steroids immunocompromised host
Vitrectomy reactivation

Semantics

Type Source Name
disease MESH acute retinal necrosis
disease MESH COVID-19
disease VO vaccination
disease MESH uveitis
disease MESH infection
disease VO dose
disease VO COVID-19 vaccine
disease IDO history
disease MESH mixed connective tissue disease
disease MESH organizing pneumonia
drug DRUGBANK Acyclovir
drug DRUGBANK Foscarnet
disease MESH retinal detachment
disease MESH scar
disease VO report
disease MESH herpes simplex
disease MESH immunocompromised host

Original Article

(Visited 2 times, 1 visits today)